A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants
A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants
Active, not recruiting · NCT04903288 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of SmartFlow Magnetic Resonance (MR) Compatible Ventricular Cannula for Administering Eladocagene Exuparvovec to Pediatric Participants | aromatic L-amino acid decarboxylase deficiency | Active, not recruiting | Phase 2 | 2026-04-24 | NCT04903288 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PTC Therapeutics | 8 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Boston Children's Hospital | Boston | United States | 343 |
| Chaim Sheba Medical Center | Ramat Gan | Israel | 8 |
| Cincinnati Children's Hospital Medical Center | Cincinnati | United States | 405 |
| Duke University Hospital | Durham | United States | 16 |
| National Taiwan University Hospital, Department of Pediatrics and Medical Genetics | Taipei | Taiwan | 1 |
| Texas Children's Hospital | Houston | United States | 187 |